New models of care and multidimensional solutions for oncological patients in the post-acute SARS-COV-2 period: a "Second Phase" also for cancer patients.
Betacoronavirus
/ pathogenicity
COVID-19
COVID-19 Testing
Clinical Laboratory Techniques
/ standards
Communicable Disease Control
/ organization & administration
Coronavirus Infections
/ diagnosis
Home Care Services, Hospital-Based
/ organization & administration
Humans
Italy
/ epidemiology
Medical Oncology
/ organization & administration
Models, Organizational
Neoplasms
/ diagnosis
Pandemics
/ prevention & control
Pneumonia, Viral
/ diagnosis
SARS-CoV-2
Triage
/ organization & administration
Journal
European review for medical and pharmacological sciences
ISSN: 2284-0729
Titre abrégé: Eur Rev Med Pharmacol Sci
Pays: Italy
ID NLM: 9717360
Informations de publication
Date de publication:
Nov 2020
Nov 2020
Historique:
entrez:
20
11
2020
pubmed:
21
11
2020
medline:
2
12
2020
Statut:
ppublish
Résumé
In Italy, SARS-CoV-2 outbreak registered a high transmission and disease rates. During the acute phase, oncologists provided to re-organize services and prioritize treatments, in order to limit viral spread and to protect cancer patients. The progressive reduction of the number of infections has prompted Italian government to gradually loosen the national confinement measures and to start the "Second phase" of measures to contain the pandemic. The issue on how to organize cancer care during this post-acute SARS-CoV-2 phase appears crucial and a reassessment of healthcare services is needed requiring new models of care for oncological patients. In order to address major challenges in cancer setting during post-acute SARS-CoV-2 phase, this work offers multidimensional solutions aimed to provide a new way to take care of cancer patients.
Identifiants
pubmed: 33215472
doi: 10.26355/eurrev_202011_23639
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM